NCT03141762

Brief Summary

Understanding the Impact of Critical Illness on Falls Risk - a 12 Month Observational Study

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2017

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2017

Completed
23 days until next milestone

Study Start

First participant enrolled

May 3, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2020

Completed
Last Updated

December 28, 2023

Status Verified

December 1, 2023

Enrollment Period

3.4 years

First QC Date

April 10, 2017

Last Update Submit

December 21, 2023

Conditions

Keywords

FallsIntensive care

Outcome Measures

Primary Outcomes (1)

  • Falls calendar - number of falls per month for 12 months, self-recorded by participant

    12-monthly falls calendar - This will record time to first fall, falls, incidence, number of falls including injurious falls.

    One per month for 12 months

Secondary Outcomes (22)

  • Muscle ultrasound imaging

    Baseline, 3, 6, and 12 months post discharge

  • Hand held dynamometry

    Baseline, 3, 6, and 12 months post discharge

  • mini-BEST

    Baseline, 3, 6, and 12 months post discharge

  • 4 metre walk test

    Baseline, 3, 6, and 12 months post discharge

  • MoCA

    Baseline, 3, 6, and 12 months post discharge

  • +17 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eligible participants will include: hospitalised adults aged 18 years and above with an ICU admission requiring invasive mechanical ventilation for at least 48 hours.

You may qualify if:

  • hospitalised adults aged 18 years
  • with an ICU admission requiring invasive mechanical ventilation for at least 48 hours and remain in ICU \> 4 days

You may not qualify if:

  • Pregnant
  • Insufficient English language skills to read and understand questionnaires and patient information consent form
  • Pre-existing documented cognitive impairment
  • Spinal cord injury or other primary neuromuscular disease or new brain injury
  • Patient unable to be followed up due to geographic location
  • New lower limb fracture on this admission
  • Liver failure with abdominal distension due to ascites requiring fortnightly drainage
  • Recent history of stroke or major surgery affecting lower limb e.g. Total knee or hip replacement in the past 12 weeks
  • Neurological disorders such as Parkinson disease or multiple sclerosis
  • Poor premorbid function defined as \<10 metres ambulation +/- gait aid independently
  • Frequent falls history defined as 3 or more falls over 2 months
  • incarcerated or safety concerns for follow up
  • discharged to palliative hospice facility
  • not expected to survive to 3 months post hospital discharge
  • unable to provide informed consent before hospital discharge due to current cognitive state (e.g. delirium, psychosis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UK Healthcare

Lexington, Kentucky, 40536, United States

Location

Melbourne Health

Melbourne, Victoria, Australia

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Selina Parry, PhD

    University of Melbourne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Investigator

Study Record Dates

First Submitted

April 10, 2017

First Posted

May 5, 2017

Study Start

May 3, 2017

Primary Completion

September 20, 2020

Study Completion

September 20, 2020

Last Updated

December 28, 2023

Record last verified: 2023-12

Locations